LONG TERM EFFICACY AND SAFETY

Clinical trials for LONG TERM EFFICACY AND SAFETY explained in plain language.

Never miss a new study

Get alerted when new LONG TERM EFFICACY AND SAFETY trials appear

Sign up with your email to follow new studies for LONG TERM EFFICACY AND SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

5-year follow-up checks if imlifidase helps kidney transplants last longer

Disease control Recruiting now

This study follows 150 people who received imlifidase before a kidney transplant to see how long their new kidney works. Researchers will check for graft failure (return to dialysis, re-transplant, or kidney removal) over 5 years. A separate group of similar patients not receivin…

Matched conditions: LONG TERM EFFICACY AND SAFETY

Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control

Last updated Jun 16, 2026 12:53 UTC

LONG TERM EFFICACY AND SAFETY

Get alerted when new LONG TERM EFFICACY AND SAFETY trials appear

5-year follow-up checks if imlifidase helps kidney transplants last longer